NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

ZYXI

Zynex Inc

Apr 29 • 04:00PM ET

2.23

Dollar change -0.01
Percentage change -0.67	%

Healthcare • Medical Distribution • USA • NASD

Peers: MDT SYK BSX ZBH IART GMED PODD TNDM CNMD AORT

| Held by: VTI GSSC IWM VXF IWO VTWO IWC JPSE AVSC EES

Scroll to Statements

Index	RUT	P/E	23.98	EPS (ttm)	0.09	Insider Own	41.24%	Shs Outstand	31.88M	Perf Week	-1.33%
Market Cap	67.41M	Forward P/E	-	EPS next Y	-0.18	Insider Trans	-0.59%	Shs Float	17.76M	Perf Month	-0.89%
Income	2.99M	PEG	-	EPS next Q	-0.12	Inst Own	25.66%	Short Float	21.53%	Perf Quarter	-72.26%
Sales	192.35M	P/S	0.35	EPS this Y	-644.44%	Inst Trans	-9.88%	Short Ratio	14.45	Perf Half Y	-74.04%
Book/sh	1.12	P/B	1.99	EPS next Y	62.24%	ROA	2.24%	Short Interest	3.82M	Perf Year	-79.62%
Cash/sh	1.31	P/C	1.70	EPS next 5Y	-	ROE	7.32%	52W Range	1.93 - 12.19	Perf YTD	-72.16%
Dividend Est.	-	P/FCF	5.55	EPS past 5Y	-18.26%	ROI	2.85%	52W High	-81.71%	Beta	0.65
Dividend TTM	-	Quick Ratio	3.63	Sales past 5Y	36.22%	Gross Margin	79.50%	52W Low	15.49%	ATR (14)	0.21
Dividend Ex-Date	Jan 05, 2022	Current Ratio	4.46	EPS Y/Y TTM	-65.34%	Oper. Margin	3.11%	RSI (14)	34.08	Volatility	8.39% 8.25%
Employees	1000	Debt/Eq	2.07	Sales Y/Y TTM	4.36%	Profit Margin	1.56%	Recom	2.33	Target Price	10.00
Option/Short	Yes / No	LT Debt/Eq	1.95	EPS Q/Q	-154.06%	Payout	0.00%	Rel Volume	0.77	Prev Close	2.24
Sales Surprise	-13.80%	EPS Surprise	-37.50%	Sales Q/Q	-2.77%	Earnings	Apr 29 AMC	Avg Volume	264.66K	Price	2.23
SMA20	-1.45%	SMA50	-44.15%	SMA200	-68.85%	Trades		Volume	205,006	Change	-0.67%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-12-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$11 → $5.50
Mar-12-25	Downgrade	Ladenburg Thalmann	Buy → Neutral
Oct-16-23	Initiated	RBC Capital Mkts	Outperform	$13
Jan-06-23	Upgrade	Piper Sandler	Neutral → Overweight	$10 → $18
Feb-28-22	Reiterated	B. Riley Securities	Buy	$15.50 → $10
Jul-16-21	Upgrade	B. Riley Securities	Neutral → Buy	$19.50
Jul-16-21	Upgrade	B. Riley Securities	Neutral → Buy	$19 → $19.50
Mar-09-21	Upgrade	Northland Capital	Market Perform → Outperform	$22.50
Feb-26-21	Downgrade	B. Riley Securities	Buy → Neutral	$19
Jan-29-21	Downgrade	Piper Sandler	Overweight → Neutral	$28 → $20
Jan-28-21	Downgrade	Northland Capital	Outperform → Market Perform	$22.50
Sep-14-20	Upgrade	H.C. Wainwright	Neutral → Buy	$25
Sep-09-20	Upgrade	Northland Capital	Market Perform → Outperform	$22.50
Jul-29-20	Upgrade	B. Riley FBR	Neutral → Buy	$28
Jul-20-20	Initiated	Piper Sandler	Overweight	$30
Jul-13-20	Downgrade	B. Riley FBR	Buy → Neutral
Jul-10-20	Reiterated	H.C. Wainwright	Neutral	$20 → $30
Jun-16-20	Downgrade	Northland Capital	Outperform → Market Perform
May-19-20	Downgrade	H.C. Wainwright	Buy → Neutral	$20
Apr-01-20	Initiated	Northland Capital	Outperform	$15

Show Previous Ratings

Today 06:57PM	Zynex, Inc. (ZYXI) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:40PM	Zynex Inc. (ZYXI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:02PM	Zynex Reports First Quarter 2025 Financial Results (PR Newswire)
05:45AM	Shareholders of Zynex, Inc. Should Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights - ZYXI (PR Newswire)
Apr-25-25 02:03PM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms Hagens Berman (GlobeNewswire)
10:19AM	Loading…
Apr-24-25 10:19AM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms - Hagens Berman (Newsfile)
Apr-23-25 07:05PM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms Hagens Berman (GlobeNewswire) +7.96%
Apr-22-25 09:15AM	Zynex Sets First Quarter 2025 Earnings Call (PR Newswire) +6.10%
08:55AM	Rewey Asset Management Q1 2025 Investment Letter (Seeking Alpha)
Apr-21-25 08:38AM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms Hagens Berman (GlobeNewswire)
Apr-18-25 02:57PM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms Hagens Berman (GlobeNewswire)
05:45AM	Zynex, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights - ZYXI (PR Newswire)
Apr-17-25 12:22PM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms - Hagens Berman (Newsfile)
Apr-16-25 05:32PM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms Hagens Berman (GlobeNewswire)
Apr-14-25 08:42AM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit Hagens Berman (GlobeNewswire)
10:44AM	Loading…
Apr-13-25 10:44AM	The 1-Minute Market Report April 13, 2025 (Seeking Alpha)
Apr-11-25 01:34PM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit Hagens Berman (GlobeNewswire)
Apr-10-25 04:27AM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit - Hagens Berman (Newsfile) -8.51%
Apr-09-25 04:31PM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit Hagens Berman (GlobeNewswire) +11.37%
Apr-07-25 04:32PM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit Hagens Berman (GlobeNewswire)
Apr-04-25 07:35AM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit - Hagens Berman (Newsfile)
Apr-03-25 01:43PM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit Hagens Berman (GlobeNewswire) -7.79%
Apr-01-25 12:25PM	Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against Zynex, Inc. (ZYXI) (Newsfile) +12.73%
05:45AM	Zynex, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights - ZYXI (PR Newswire)
Mar-31-25 11:45AM	Wolf Haldenstein informs investors that Zynex, Inc. has been sued (GlobeNewswire)
08:05AM	The 1-Minute Market Report March 30, 2025 (Seeking Alpha)
Mar-27-25 01:04PM	Investors in Zynex, Inc. Should Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights ZYXI (GlobeNewswire)
12:25PM	Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Action Has Been Filed Against Zynex, Inc. (ZYXI) (Newsfile)
09:02AM	Wolf Haldenstein informs investors that Zynex, Inc. has been sued (PR Newswire)
Mar-26-25 05:14PM	Wolf Haldenstein informs investors that Zynex, Inc. has been sued (GlobeNewswire)
11:00AM	Loading…
Mar-22-25 11:00AM	Investors To Focus On PCE Price Index Print As Cintas, Lululemon To Report Earnings (SeekingAlpha)
Mar-12-25 07:46AM	Q4 2024 Zynex Inc Earnings Call (Thomson Reuters StreetEvents) -51.29%
03:06AM	Zynex Inc (ZYXI) Q4 2024 Earnings Call Highlights: Navigating Challenges and Opportunities (GuruFocus.com)
Mar-11-25 05:35PM	Zynex Inc. (ZYXI) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:08PM	Zynex Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire)
Mar-03-25 09:15AM	Zynex Sets Fourth Quarter and Year End 2024 Earnings Call (PR Newswire)
Dec-17-24 09:15AM	Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States (PR Newswire)
Dec-12-24 09:15AM	Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters (PR Newswire)
Dec-06-24 10:44AM	Zynex completes clinical verification trial of pulse oximeter (Medical Device Network)
Dec-05-24 09:15AM	Zynex Announces Completion of Its Laser Pulse Oximetry Trial (PR Newswire)
Dec-03-24 09:15AM	Zynex Announces Open Oximetry Project Membership (PR Newswire)
Nov-05-24 07:00AM	Building Momentum: Zynex Inc.'s (NASDAQ: ZYXI) Steady Rise in the Pain Management Market (News Direct)
Oct-25-24 12:26PM	Q3 2024 Zynex Inc Earnings Call (Thomson Reuters StreetEvents) +6.17%
03:20AM	Zynex Inc (ZYXI) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Oct-24-24 05:10PM	Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates (Zacks)
04:01PM	Zynex Reports Third Quarter 2024 Financial Results (PR Newswire)
Oct-16-24 09:15AM	Zynex Sets Third Quarter 2024 Earnings Call (PR Newswire)
Oct-09-24 07:50AM	Zynex price target lowered to $11 from $12 at RBC Capital (TipRanks)
Sep-04-24 09:53AM	FDA clears Zynexs TensWave device for pain management (Medical Device Network)
09:15AM	Zynex to Present at the HC Wainwright Global Investment Conference (PR Newswire)
Sep-03-24 09:15AM	Zynex Obtains FDA clearance for new Pain Management Device (PR Newswire)
Aug-09-24 01:02AM	Insider Sale: COO Anna Lucsok Sells 24,875 Shares of Zynex Inc (ZYXI) (GuruFocus.com)
Jul-31-24 09:42AM	Zynex Inc. CEO Thomas Sandgaard Discusses Significant Company Growth and Future Innovations (News Direct) +9.49%
Jul-26-24 04:37PM	Why Zynex Plunged Today (Motley Fool) -12.37% -6.61%
12:34PM	Q2 2024 Zynex Inc Earnings Call (Thomson Reuters StreetEvents)
07:36AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jul-25-24 05:35PM	Zynex Inc. (ZYXI) Q2 Earnings and Revenues Lag Estimates (Zacks)
04:01PM	Zynex Reports Second Quarter 2024 Financial Results (PR Newswire)
Jul-17-24 09:15AM	Zynex Sets Second Quarter 2024 Earnings Call (PR Newswire)
Jul-11-24 09:15AM	Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces (PR Newswire)
Jun-26-24 12:00PM	All You Need to Know About Zynex (ZYXI) Rating Upgrade to Buy (Zacks)
Jun-24-24 06:00AM	3 Short-Squeeze Stocks Poised for a Jaw-Dropping Rally (InvestorPlace)
Jun-19-24 06:00AM	Analyst Predictions: 3 Stocks Pegged to Soar Over 40% in One Year (InvestorPlace)
Jun-12-24 09:40AM	Is Zynex (ZYXI) Stock Undervalued Right Now? (Zacks)
Jun-10-24 09:30AM	Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024 (PR Newswire)
May-27-24 09:40AM	Should Value Investors Buy Zynex (ZYXI) Stock? (Zacks)
May-23-24 12:45PM	Zynex (ZYXI) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
May-09-24 09:40AM	Are Investors Undervaluing Zynex (ZYXI) Right Now? (Zacks)
09:15AM	Zynex to Present at the RBC Capital Markets Global Healthcare Conference (PR Newswire)
May-07-24 12:45PM	3 Reasons Growth Investors Will Love Zynex (ZYXI) (Zacks)
09:15AM	Zynex Executives Recognized Among Top 25 in Medical Technology (PR Newswire)
May-02-24 08:55AM	Zynex, Inc. (NASDAQ:ZYXI) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:01AM	Zynex Inc (ZYXI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Seizing ... (GuruFocus.com)
Apr-30-24 08:58PM	ZYXI Stock Earnings: Zynex Misses Revenue for Q1 2024 (InvestorPlace) +7.29%
05:44PM	Zynex Inc (ZYXI) Q1 2024 Earnings: Revenue Meets Expectations, EPS Falls Short (GuruFocus.com)
04:01PM	Zynex Reports First Quarter 2024 Financial Results (PR Newswire)
Apr-18-24 09:15AM	Zynex Sets First Quarter 2024 Earnings Call (PR Newswire) -5.14%
Apr-02-24 02:58PM	3 Industrial Stocks Short Sellers Are Hammering: Cracks in the Foundation? (InvestorPlace)
09:15AM	Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award (PR Newswire)
Mar-02-24 08:43AM	Zynex, Inc. (NASDAQ:ZYXI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 12:05PM	Zynex Price Target Raised by RBC Capital, HC Wainwright Analysts (Exec Edge) -9.29%
Feb-29-24 05:20PM	Zynex Inc. (ZYXI) Q4 Earnings and Revenues Miss Estimates (Zacks)
04:39PM	Zynex Inc (ZYXI) Reports 17% Revenue Growth in FY 2023, Announces New $20 Million Stock ... (GuruFocus.com)
04:01PM	Zynex Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-22-24 09:15AM	Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call (PR Newswire)
Feb-20-24 09:15AM	Zynex Introduces New Products (PR Newswire)
Feb-08-24 09:00AM	Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023 (GlobeNewswire)
Feb-06-24 09:15AM	Zynex Receives FDA Clearance for its Next Generation NMES Device (PR Newswire)
Feb-02-24 09:15AM	Zynex Recognized in Top 25 Medical Device Companies for 2024 (PR Newswire)
Jan-28-24 01:27PM	3 Unloved Growth Stocks Poised for a Major Turnaround (InvestorPlace)
Jan-08-24 09:15AM	Zynex to Participate at the Needham Annual Growth Conference (PR Newswire)
Dec-15-23 01:10PM	Full Video Coverage Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum (CorpGov.com)
Dec-08-23 10:13AM	12 Best Healthcare Stocks For the Long-Term (Insider Monkey)
Nov-27-23 02:08PM	Healthcare Edge: Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum (Exec Edge)
Nov-15-23 09:15AM	Zynex Ranked in Forbes List of 'America's Most Successful Small-Cap Companies 2024' (PR Newswire)
Nov-13-23 09:15AM	Zynex Submits FDA Application for its Next Generation NMES Device (PR Newswire)
Nov-09-23 09:15AM	Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive Year (PR Newswire)
Nov-01-23 10:30AM	EXCLUSIVE: Medical Devices Firm Zynex Launches New $20M Share Repurchase Program (Benzinga)
09:15AM	Zynex Announces Share Repurchase Program (PR Newswire)
Oct-31-23 06:45AM	Zynex Announces Review of Strategic Alternatives (PR Newswire)

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. It also develops a new blood volume monitor for use in hospitals and surgery centers. The company was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Mar 03 '25	Sale	7.15	10,000	71,500	10,050	Mar 05 07:58 PM
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Feb 03 '25	Sale	7.68	10,000	76,800	19,738	Feb 03 07:00 PM
Daniel Moorhead	Officer	Feb 03 '25	Proposed Sale	7.84	20,000	156,800		Feb 03 09:00 AM
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Jan 02 '25	Sale	7.88	10,000	78,800	26,299	Jan 03 07:00 PM
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Dec 02 '24	Sale	8.08	10,000	80,800	35,190	Dec 03 07:00 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 14 '24	Sale	8.09	2,000	16,180	14,603,662	Nov 18 07:00 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 12 '24	Sale	9.24	2,000	18,480	14,607,662	Nov 13 06:03 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 07 '24	Sale	9.17	2,000	18,340	14,613,662	Nov 13 06:03 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 11 '24	Sale	9.09	2,000	18,180	14,609,662	Nov 13 06:03 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 08 '24	Sale	8.77	2,000	17,540	14,611,662	Nov 13 06:03 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 13 '24	Sale	8.37	2,000	16,740	14,605,662	Nov 13 06:03 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 06 '24	Sale	8.82	2,000	17,640	14,615,662	Nov 06 08:05 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 04 '24	Sale	8.67	2,000	17,340	14,619,350	Nov 06 08:05 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 05 '24	Sale	8.05	2,000	16,100	14,617,662	Nov 06 08:05 PM
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Nov 01 '24	Sale	8.59	10,000	85,900	44,878	Nov 04 06:00 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Oct 30 '24	Sale	8.92	2,000	17,840	14,625,350	Nov 01 06:39 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Oct 31 '24	Sale	8.82	2,000	17,640	14,623,350	Nov 01 06:39 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 01 '24	Sale	8.63	2,000	17,260	14,621,350	Nov 01 06:39 PM
Daniel Moorhead	Officer	Nov 01 '24	Proposed Sale	8.63	30,000	258,900		Nov 01 09:20 AM
Sandgaard Thomas	Officer	Oct 30 '24	Proposed Sale	8.92	100,000	892,000		Oct 30 12:01 PM
Lucsok Anna	CHIEF OPERATING OFFICER	Aug 06 '24	Sale	8.01	16,792	134,504	25,063	Aug 08 07:05 PM
Lucsok Anna	CHIEF OPERATING OFFICER	Aug 07 '24	Sale	8.03	8,083	64,906	16,980	Aug 08 07:05 PM
Disbrow Joshua R.	Director	Jul 29 '24	Buy	8.32	7,000	58,233	72,000	Jul 30 06:25 PM
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Jul 30 '24	Sale	8.24	15,000	123,600	46,571	Jul 30 06:23 PM
Daniel Moorhead	Officer	Jul 30 '24	Proposed Sale	8.34	15,000	125,100		Jul 30 09:00 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ZYXI

Zynex Inc

Upgrade your FINVIZ experience